دورية أكاديمية
Comparison of Estetrol Exposure between Women and Mice to Model Preclinical Experiments and Anticipate Human Treatment.
| العنوان: | Comparison of Estetrol Exposure between Women and Mice to Model Preclinical Experiments and Anticipate Human Treatment. |
|---|---|
| المؤلفون: | Gallez, Anne, Nys, Gwenaël, Wuidar, Vincent, Dias Da Silva, Isabelle, Taziaux, Mélanie, Kinet, Virginie, Tskitishvili, Ekaterine, Noël, Agnès, Foidart, Jean-Michel, Piel, Géraldine, Fillet, Marianne, Pequeux, Christel |
| المصدر: | International Journal of Molecular Sciences, 24 (11), 9718 (2023-06-03) |
| بيانات النشر: | MDPI AG |
| سنة النشر: | 2023 |
| المجموعة: | University of Liège: ORBi (Open Repository and Bibliography) |
| مصطلحات موضوعية: | estetrol, exposure, human, mice, pharmacokinetics, route of administration, Estrogens, Humans, Female, Animals, General Medicine, Human health sciences, Reproductive medicine (gynecology, andrology, obstetrics), Pharmacy, pharmacology & toxicology, Sciences de la santé humaine, Médecine de la reproduction (Gynécologie, andrologie, obstétrique), Pharmacie, pharmacologie & toxicologie |
| الوصف: | peer reviewed ; Estetrol (E4) is a natural estrogen with promising therapeutic applications in humans. The European Medicines Agency and the Food and Drug Administration have approved the use of 15 mg E4/3 mg drospirenone for contraceptive indication. Phase III clinical trials with 15-20 mg E4 for the relief of climacteric complaints are currently running. Relevant data from preclinical animal models are needed to characterize the molecular mechanisms and the pharmacological effects of E4 and possibly to reveal new therapeutic applications and to anticipate potential adverse effects. Therefore, it is important to design experimental procedures in rodents that closely mimic or anticipate human E4 exposure. In this study, we compared the effects of E4 exposure after acute or chronic administration in women and mice. Women who received chronic E4 treatment per os at a dose of 15 mg once daily reached a steady state within 6 to 8 days, with a mean plasma concentration of 3.20 ng/mL. Importantly, with subcutaneous, intraperitoneal or oral administration of E4 in mice, a stable concentration over time that would mimic human pharmacokinetics could not be achieved. The use of osmotic minipumps continuously releasing E4 for several weeks provided an exposure profile mimicking chronic oral administration in women. Measurements of the circulating concentration of E4 in mice revealed that the mouse equivalent dose necessary to mimic human treatment does not fit with the allometric prediction. In conclusion, this study highlights the importance of precise definition of the most appropriate dose and route of administration to utilize when developing predictive preclinical animal models to mimic or anticipate specific human treatment. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 1661-6596 1422-0067 |
| العلاقة: | https://www.mdpi.com/1422-0067/24/11/9718/pdfTest; urn:issn:1661-6596; urn:issn:1422-0067; https://orbi.uliege.be/handle/2268/304468Test; info:hdl:2268/304468; https://orbi.uliege.be/bitstream/2268/304468/1/ijms-24-09718.pdfTest; scopus-id:2-s2.0-85161825113; info:pmid:37298669 |
| DOI: | 10.3390/ijms24119718 |
| الإتاحة: | https://doi.org/10.3390/ijms24119718Test https://orbi.uliege.be/handle/2268/304468Test https://orbi.uliege.be/bitstream/2268/304468/1/ijms-24-09718.pdfTest |
| حقوق: | open access ; http://purl.org/coar/access_right/c_abf2Test ; info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.F6F3B416 |
| قاعدة البيانات: | BASE |
Full Text Finder | تدمد: | 16616596 14220067 |
|---|---|
| DOI: | 10.3390/ijms24119718 |